- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02939404
Food Intake Response to Short-Term Modifications of Metabolism in Humans
Energy Intake Response to Short-Term Alterations of Energy Expenditure in Humans
One reason people gain weight is eating more calories from food than what they need for energy over 24 hours. Metabolism is the amount of energy a person uses over 24 hours. Researchers want to study the relationship between changes in metabolism and how much a person eats.
Objectives:
To see how much food a person eats when the body's temperature is cooled. To study how changes in metabolism may alter the amount of food a person eats.
Eligibility:
Healthy people ages 18-55.
Design:
Participants will stay at NIH for 20 days.
During the first 4 days, participants will have:
- Medical exam
- Electrocardiogram
- Blood and urine tests. One blood test includes drinking a sugar solution.
- DXA body composition scan
- Questions about foods they like, physical activity, and personal behavior
- Exercise test on a stationary bicycle
Participants will spend 24-hour periods in a metabolic chamber. The chamber will be at normal room temperature or cooler.
Some times, participants will eat a diet that matches their daily needs (fixed or eucaloric). Other times, they can eat as much as they wish from a vending machine (ad libitum).
Participants will have blood and urine collected.
Participants will swallow an ingestible wireless sensor and wear a small data recorder device.
On the second to last day, participants will stay in the metabolic chamber but only consume water and non-caffeinated sugar-free beverages.
Participants will come back for 1-day visits at six months and one year from the first admission. They will have blood and urine tests, and a DXA scan. They will answer questions on physical activity and food habits.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85014
- NIDDK, Phoenix
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Study Population
Description
- INCLUSION CRITERIA:
- Premenopausal women and men <55 years of age
- Body weight <204 kg (<450 pounds) and >= 36 kg (>= 80 pounds)
- Stable weight (+/-5% within past 6 months) as determined by volunteer report
- Healthy, as determined by medical history, physical examination, and laboratory tests
EXCLUSION CRITERIA:
- Age <18 years
- Weight greater than or equal to 204 kg (greater than or equal to 450 pounds, maximum weight of the iDXA machine as per manufacturer s manual), or weight <36 kg (<80 pounds, minimum weight allowed based on the NIH guidelines of blood drawing for research purposes)
- Use of medications affecting metabolism and appetite in the last three months
- Expresses unwillingness to consume all food given during the weight maintaining diet portions of the study (e.g., due to strict dietary restrictions including allergies or vegetarian or kosher diet)
- Current use of tobacco products, marijuana, amphetamines, cocaine, or intravenous drug use
- Current pregnancy, pregnancy within the past 6 months or lactation
History or clinical manifestation of:
- Type 1 and Type 2 diabetes mellitus
- History of surgery for the treatment of obesity
- Endocrine disorders, such as Cushing s disease, pituitary disorders, and hypo and hyperthyroidism
- Pulmonary disorders, including chronic obstructive pulmonary disease
- Cardiovascular diseases, including coronary heart disease, heart failure, arrhythmias, and peripheral artery disease
- High blood pressure by sitting blood pressure measurement using an appropriate cuff higher than 140/90 mmHg on two or more occasions, or current antihypertensive therapy
- Liver disease, including cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 2x normal
- Gastrointestinal disease including Crohn s disease, ulcerative colitis, celiac disease or other malabsorptive disorders
- Abnormal kidney function (eGFR <60 mL/min/1.73m(2))
- Central nervous system disease, including previous history of cerebrovascular accidents, dementia, neurodegenerative disorders or history of severe head trauma
- Cancer requiring treatment in the past five years, except for nonmelanoma skin cancers or cancers that have clearly been cured
- Infectious disease such as active tuberculosis, HIV (by self report), chronic coccidiomycoses or other chronic infections that might influence EE and weight
- Diagnosis of binge eating disorder, anorexia and major psychiatric disorders based upon the DSM-IV including depression, schizophrenia and psychosis, which may impact the ability of the participant to be in the respiratory chamber for 24 hour time periods
- Chronic ethanol use (more than 3 drinks/day)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1. Chamber at 24C, fixed diet
Chamber at room temperature (24C) with a fixed eucaloric diet
|
23.25 hours inside respiratory chamber with the temperature set to 24°C
A diet that matches the participant's caloric needs
Other Names:
|
|
Experimental: 2. Chamber at 24C, ad libitum diet
Chamber at room temperature (24C) with an ad libitum diet (self-select how much food they wish to eat)
|
23.25 hours inside respiratory chamber with the temperature set to 24°C
Participants can eat as much as they want
|
|
Experimental: 3. Chamber at 19C, fixed diet
Chamber at cold temperature (16C) with a fixed eucaloric diet
|
A diet that matches the participant's caloric needs
Other Names:
23.25 hours inside respiratory chamber with the temperature set to19°C
|
|
Experimental: 4. Chamber at 19C, ad libitum diet
Chamber at cold temperature (19C) with an ad libitum diet (self-select how much food they wish to eat)
|
Participants can eat as much as they want
23.25 hours inside respiratory chamber with the temperature set to19°C
|
|
Experimental: 5. Chamber at 24C, fasting
Chamber at room temperature (24C) fasting while in chamber and 12 hours before
|
23.25 hours inside respiratory chamber with the temperature set to 24°C
Participants do not eat for 12 hours before and 24 hours in chamber
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
24-hour Energy Expenditure (kcal)
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
|
Energy expenditure (EE) as measured during 24 hours in a whole-room calorimeter
|
Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
|
|
24-hour Energy Intake (kcal)
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
|
Energy intake as measured during 24 hours in a whole-room calorimeter
|
Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
24- Hour Respiratory Quotient (RQ)
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
|
RQ, an approximation for the ratio of carbohydrate-to-fat oxidation rates, is measured while in the chamber
|
Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
|
|
Leptin
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
Plasma leptin (ng/ml)
|
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
|
Secretin
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
Plasma secretin (ng/ml)
|
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
|
Ghrelin
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
Plasma grehlin (pg/ml)
|
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
|
FGF-21
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
Plasma FGF-21 (pg/ml)
|
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
|
Core Body Temperature (C)
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
Core body temperature measured in chamber
|
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
|
|
Weight Change at 6 Months
Time Frame: 6 months
|
Weight change from baseline to 6 months
|
6 months
|
|
Weight Change at 12 Months
Time Frame: 12 months
|
Weight change from baseline to 12 months
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Douglas Chang, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Publications and helpful links
General Publications
- Hollstein T, Basolo A, Ando T, Votruba SB, Walter M, Krakoff J, Piaggi P. Recharacterizing the Metabolic State of Energy Balance in Thrifty and Spendthrift Phenotypes. J Clin Endocrinol Metab. 2020 May 1;105(5):1375-92. doi: 10.1210/clinem/dgaa098.
- Hollstein T, Heinitz S, Ando T, Rodzevik TL, Basolo A, Walter M, Chang DC, Krakoff J, Piaggi P. Metabolic Responses to 24-Hour Fasting and Mild Cold Exposure in Overweight Individuals Are Correlated and Accompanied by Changes in FGF21 Concentration. Diabetes. 2020 Jul;69(7):1382-1388. doi: 10.2337/db20-0153. Epub 2020 Apr 27.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 999917004
- 17-DK-N004 (Other Identifier: NIDDK)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
Clinical Trials on Normal temperature
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical UniversityRecruitingNecrotizing Enterocolitis | Bloody Stool | Neutral TemperatureChina
-
Thomas Jefferson UniversityUnknownHypothermia | Cerebral HemorrhageUnited States
-
Ege UniversityCompletedPrematurity | Feeding Disorder NeonatalTurkey
-
Indiana UniversityUnited States Department of DefenseNot yet recruiting
-
Karolinska InstitutetDanderyd Hospital; Stockholm South General HospitalWithdrawnSepsis | Critical Illness | Fluid Overload | Hemodynamic InstabilitySweden
-
Yinan QuQilu Hospital of Shandong UniversityCompletedWounds and Injuries | Body Temperature Changes | Heat Stress Disorders | Multiple Organ DysfunctionChina
-
Ankara City Hospital BilkentCompletedHypothermia | Orthopedic Disorder | Hip ArthropathyTurkey
-
Ajou University School of MedicineCompletedTrauma | Core TemperatureKorea, Republic of
-
Poitiers University HospitalCompletedContinuous Non Invasive Cutaneous Temperature | Zero Heat Flux Method | Esophageal Temperature | Arterial Temperature | Intracerebral TemperatureFrance
-
University of BonnDLR German Aerospace CenterCompletedResting Energy ExpenditureGermany